C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/53 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2574594
Compounds of the formula (I): and pharmaceutically acceptable salts thereof, wherein Q1 and R1 are defined herein, inhibit the IGF- 1 R enzyme and are useful for the treatment and/or prevention of various diseases and conditions that respond to treatment by inhibition of tyrosine kinases.
L'invention concerne des composés de la formule (I) et des sels pharmaceutiquement acceptables de ceux-ci, dans lesquels Q1 et R1 sont définis dans le descriptif, inhibent l'enzyme IGF-1R et sont utilisés dans le traitement et/ou la prévention de maladies et états divers qui réagissent au traitement par inhibition des tyrosine kinases.
Crew Andrew Philip
Mulvihill Mark Joseph
Werner Douglas Scott
Cassan Maclean
Osi Pharmaceuticals Inc.
LandOfFree
Imidazopyrazine as tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyrazine as tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyrazine as tyrosine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1661569